Early bronchoconstriction and late eosinophilic inflammation in one composite adult with occupational cat allergy are matched, phase by phase, to inhaled agents in this NU559 respiratory case study. Searches like "nu 559 unit 4 assignment example", "nu559 unit 4 sample" and "nu559 unit 4 example" land here.
What a finished NU559 Unit 4 respiratory case study looks like
Four to five pages in case study format: a half-page presentation, a mechanism section in two parts, a therapy section mirroring those two parts, and a short discussion of what the current regimen misses. The presentation gives her symptoms by timing, a rescue inhaler used on [five] days of [seven], night waking [twice] a month, and spirometry with an FEV1 of [74] percent predicted that rises [15] percent after a bronchodilator. The mechanism section follows allergen cross-linking IgE on mast cells to histamine and leukotriene release within minutes, then the Th2 cytokines IL-4, IL-5 and IL-13 recruiting eosinophils over the following hours. The therapy section pins a short-acting beta-2 agonist to the first process and an inhaled corticosteroid to the second, explaining why a reliever alone leaves the late phase untouched.
How a NU559 Unit 4 example is structured
Timing organizes the whole case. Every finding is placed on one of two clocks, minutes or hours, and every drug is placed on the clock it can affect. That arrangement is what turns a list of asthma drugs into an argument. The beta-2 agonist section follows the receptor to cyclic AMP and smooth muscle relaxation, which accounts for both its speed and its inability to reduce inflammation. The corticosteroid section explains gene transcription effects that reduce eosinophils, mast cells and airway hyperresponsiveness over days rather than minutes, which is why regular use matters more than the timing of any single dose. A shorter paragraph places a leukotriene receptor antagonist and a long-acting muscarinic antagonist on the map for completeness. The discussion closes on her workplace, where allergen exposure is the upstream step no inhaler reaches, bracketed as a referral question.
Minutes and hours on one line
A horizontal figure marks the cat exposure at zero, early bronchoconstriction within [15] minutes and the late phase at [four to eight] hours. Each symptom she reports is placed on that line before any mechanism is named.
Mast cells in the first minutes
Allergen bridging IgE on mast cells releases preformed histamine and newly made leukotrienes, contracting airway smooth muscle quickly. The case pairs this with [albuterol], a beta-2 agonist that raises cyclic AMP and relaxes the muscle within minutes.
Eosinophils in the later hours
Th2 cytokines recruit and sustain eosinophils, and the airway wall swells and grows hyperresponsive. An inhaled corticosteroid such as [budesonide] works through gene transcription in those cells, so its benefit builds over days and cannot be seen after a single dose.
What a reliever cannot reach
Relying on [albuterol] alone treats the first clock and leaves the second running, and the case explains why frequent reliever use signals uncontrolled inflammation. GINA stopped recommending reliever-only treatment for adults and adolescents in 2019, a change the case cites with its year.
Exposure upstream of every drug
Her daily contact with animals is the step no inhaler touches. The closing paragraph raises occupational asthma as a question for referral and workplace review, bracketed as the treating clinician's decision, and names the history detail that supports asking it.
Where marks go in NU559 Unit 4
Most rubrics for this case look for two mechanisms kept distinct and each matched to its agent. A paper that describes asthma as one process and then lists inhalers falls short, since the prompt was built around the gap between minutes and hours. Labeling the corticosteroid a bronchodilator, or implying it relieves an attack in progress, is a costly factual slip. So is describing the beta-2 agonist's mechanism without explaining why it cannot touch inflammation, the point on which the case turns. Graders often deduct for spirometry quoted without interpretation, since a [15] percent change after bronchodilator means something here. Lesser losses come from ignoring the occupational trigger, from a leukotriene antagonist pinned to the wrong receptor, and from doses stated as recommendations.
Get a NU559 Unit 4 example written to your instructions
Asthma, COPD or a mixed picture all suit this format. Forward the NU559 Unit 4 case with any spirometry it supplies plus its rubric, and the sample, patient composite and agents bracketed, returns in 24-48h with each airway process matched to the drug acting on it. Nothing is charged for a first one.
NU559 Unit 4 questions, answered
Should the case study cover biologic therapies?
Only if the prompt or the severity of the case calls for them. Anti-IgE and anti-IL-5 agents fit neatly on the same mechanism map, and a sentence placing them can show range. For a patient with moderate symptoms on a reliever alone, however, a long section on biologics suggests the paper has drifted away from the person the case describes.
How much spirometry interpretation is expected?
Enough to connect the numbers to the mechanism. A reduced FEV1 that improves meaningfully after a bronchodilator supports reversible smooth muscle constriction, which is the first process the paper describes. Stating the values without saying what they indicate is a common gap; a sentence or two linking reversibility to the early phase usually satisfies this part of the rubric.
Can a real patient from work supply the case details?
It is safer not to, even with names removed, because an occupation combined with a trigger can point to one person. Composite patients assembled from typical features give the same teaching value. The sample uses a composite throughout and brackets every value, and a student paper can do the same while still meeting a rubric's demand for realistic detail.